Potential microRNA panel for the diagnosis and prediction of overall survival of hepatocellular carcinoma with hepatitis B virus infection

被引:0
|
作者
Qi Zhang [1 ]
Hai-Feng Xu [2 ]
Wen-Yue Song [1 ]
Peng-Jun Zhang [2 ]
Yong-Bo Song [1 ]
机构
[1] School of Life Science and Biopharmaceutics,Shenyang Pharmaceutical University
[2] Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing), Interventional Therapy Department, Peking University Cancer Hospital and Institute
基金
国家重点研发计划;
关键词
Hepatitis B virus infection; Hepatocellular carcinoma; MicroRNAs; Cirrhosis; Biomarker; Tissue;
D O I
暂无
中图分类号
R735.7 [肝肿瘤]; R512.62 [];
学科分类号
100214 ; 100401 ;
摘要
BACKGROUND In hepatocellular carcinoma(HCC), abnormal expression of multiple micro RNAs(miRNAs) has been shown to be involved in the malignant biological behavior of liver cancer. The vast majority of liver cancer cases in China are closely related to hepatitis B virus(HBV) infection, but there are few studies on the changes of miRNA expression in the progression from HBV infection to hepatoma.AIM To explore the role of miRNAs in the progression of HBV infection to cirrhosis and even to liver cancer.METHODS We screened differentially expressed miRNAs in 40 HBV cirrhosis, 40 normal and15 HCC tissues by using a Taq Man Low Density Array and real time quantitative polymerase chain reaction. To evaluate the power of the selected miRNAs to predict disease, we calculated the area under the receiver-operating-characteristic curves. The overall survival of HBV cirrhosis patients was analyzed via KaplanMeier analysis.RESULTS The levels of miR-375, miR-122 and miR-143 were significantly lower in HBV cirrhosis tissues, while miR-224 was significantly higher than in the controls(P <0.0001). The area under the curves of the receiver-operating-characteristic curve for the 4-miRNA panel was 0.991(95%CI: 0.974-1). Patients with a lower expression level of miR-224 or higher expression levels of miR-375, miR-122 and miR-143 had longer overall survival.CONCLUSIONThe four miRNAs(miR-375, miR-122, miR-143 and miR-224) may be helpful for early diagnosis of HBV infection, HBV cirrhosis, and prediction of its overall survival.
引用
收藏
页码:383 / 393
页数:11
相关论文
共 50 条
  • [31] Global Regulation on microRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma
    Liu, Angela M.
    Zhang, Chunsheng
    Burchard, Julja
    Fan, S. T.
    Wong, Kwong-Fai
    Dai, Hongyue
    Poon, Ronnie T.
    Luk, John M.
    OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2011, 15 (03) : 187 - 191
  • [32] Serum MicroRNAs as Biomarkers in Hepatitis C: Preliminary Evidence of a MicroRNA Panel for the Diagnosis of Hepatocellular Carcinoma
    Weis, Anna
    Marquart, Louise
    Calvopina, Diego A.
    Genz, Berit
    Ramm, Grant A.
    Skoien, Richard
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (04):
  • [33] Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patients
    Moustafa Nouh Elemeery
    Ahmed Noah Badr
    Marwa Anwar Mohamed
    Doaa Ahmed Ghareeb
    World Journal of Gastroenterology, 2017, 23 (21) : 3864 - 3875
  • [34] Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patients
    Elemeery, Moustafa Nouh
    Badr, Ahmed Noah
    Mohamed, Marwa Anwar
    Ghareeb, Doaa Ahmed
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (21) : 3864 - 3875
  • [35] A prediction nomogram for hepatitis B virus-associated hepatocellular carcinoma
    Zhang, Yijin
    Wan, Gang
    Li, Hongjie
    Gao, Lili
    Liu, Nan
    Gao, Ping
    Liu, Yaping
    Gao, Xuesong
    Duan, Xuefei
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2024, 59 (01) : 70 - 77
  • [36] RISK PREDICTION OF NON-CIRRHOTIC HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION
    Jeng, W. -J.
    Yang, H. I.
    Liu, J.
    Lee, M. -H.
    Jen, C. -L.
    Batrla-Utermann, R.
    Lu, S. -N.
    Wang, L. -Y.
    You, S. -L.
    Chen, C. -J.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S545 - S545
  • [37] Hepatocellular carcinoma and hepatitis B virus
    Chan, HLY
    Sung, JJY
    SEMINARS IN LIVER DISEASE, 2006, 26 (02) : 153 - 161
  • [38] Hepatitis B virus and hepatocellular carcinoma
    Arbuthnot, P
    Kew, M
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2001, 82 (02) : 77 - 100
  • [39] Hepatitis B virus and hepatocellular carcinoma
    Bruix, J
    Llovet, JM
    JOURNAL OF HEPATOLOGY, 2003, 39 : S59 - S63
  • [40] Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma
    Kubo, Shoji
    Takemura, Shigekazu
    Tanaka, Shogo
    Shinkawa, Hiroji
    Nishioka, Takayoshi
    Nozawa, Akinori
    Kinoshita, Masahiko
    Hamano, Genya
    Ito, Tokuji
    Urata, Yorihisa
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (27) : 8249 - 8255